Literature DB >> 19176630

The region approximately between amino acids 81 and 137 of proteinase K-resistant PrPSc is critical for the infectivity of the Chandler prion strain.

Ryo Shindoh1, Chan-Lan Kim, Chang-Hyun Song, Rie Hasebe, Motohiro Horiuchi.   

Abstract

Although the major component of the prion is believed to be the oligomer of PrP(Sc), little information is available concerning regions on the PrP(Sc) molecule that affect prion infectivity. During the analysis of PrP(Sc) molecules from various prion strains, we found that PrP(Sc) of the Chandler strain showed a unique property in the conformational-stability assay, and this property appeared to be useful for studying the relationship between regions of the PrP(Sc) molecule and prion infectivity. Thus, we analyzed PrP(Sc) of the Chandler strain in detail and analyzed the infectivities of the N-terminally denatured and truncated forms of proteinase K-resistant PrP. The N-terminal region of PrP(Sc) of the Chandler strain showed region-dependent resistance to guanidine hydrochloride (GdnHCl) treatment. The region approximately between amino acids (aa) 81 and 137 began to be denatured by treatment with 1.5 M GdnHCl. Within this stretch, the region comprising approximately aa 81 to 90 was denatured almost completely by 2 M GdnHCl. Furthermore, the region approximately between aa 90 and 137 was denatured completely by 3 M GdnHCl. However, the C-terminal region thereafter was extremely resistant to the GdnHCl treatment. This property was not observed in PrP(Sc) molecules of other prion strains. Denaturation of the region between aa 81 and 137 by 3 M GdnHCl significantly prolonged the incubation periods in mice compared to that for the untreated control. More strikingly, the denaturation and removal of this region nearly abolished the infectivity. This finding suggests that the conformation of the region between aa 81 and 137 of the Chandler strain PrP(Sc) molecule is directly associated with prion infectivity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19176630      PMCID: PMC2663276          DOI: 10.1128/JVI.01740-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein.

Authors:  L Zulianello; K Kaneko; M Scott; S Erpel; D Han; F E Cohen; S B Prusiner
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes.

Authors:  Salit Tzaban; Gilgi Friedlander; Oshrat Schonberger; Lior Horonchik; Yifat Yedidia; Gideon Shaked; Ruth Gabizon; Albert Taraboulos
Journal:  Biochemistry       Date:  2002-10-22       Impact factor: 3.162

3.  Strain-specified relative conformational stability of the scrapie prion protein.

Authors:  D Peretz; M R Scott; D Groth; R A Williamson; D R Burton; F E Cohen; S B Prusiner
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

4.  Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc.

Authors:  Gianluca Moroncini; Nnennaya Kanu; Laura Solforosi; Gil Abalos; Glenn C Telling; Mark Head; James Ironside; Jeremy P Brockes; Dennis R Burton; R Anthony Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

5.  Biological and biochemical characterization of sheep scrapie in Japan.

Authors:  Motohiro Horiuchi; Takuya Nemoto; Naotaka Ishiguro; Hidefumi Furuoka; Shirou Mohri; Morikazu Shinagawa
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

6.  Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies.

Authors:  Chan-Lan Kim; Atsushi Umetani; Toshio Matsui; Naotaka Ishiguro; Morikazu Shinagawa; Motohiro Horiuchi
Journal:  Virology       Date:  2004-03-01       Impact factor: 3.616

7.  Mouse-adapted ovine scrapie prion strains are characterized by different conformers of PrPSc.

Authors:  Alana M Thackray; Lee Hopkins; Michael A Klein; Raymond Bujdoso
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

8.  Synthetic mammalian prions.

Authors:  Giuseppe Legname; Ilia V Baskakov; Hoang-Oanh B Nguyen; Detlev Riesner; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  Science       Date:  2004-07-30       Impact factor: 47.728

9.  Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD.

Authors:  Silvio Notari; Sabina Capellari; Armin Giese; Ingo Westner; Agostino Baruzzi; Bernardino Ghetti; Pierluigi Gambetti; Hans A Kretzschmar; Piero Parchi
Journal:  J Biol Chem       Date:  2004-01-29       Impact factor: 5.157

10.  Dominant-negative inhibition of prion replication in transgenic mice.

Authors:  Véronique Perrier; Kiyotoshi Kaneko; Jiri Safar; Julie Vergara; Patrick Tremblay; Stephen J DeArmond; Fred E Cohen; Stanley B Prusiner; Andrew C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

View more
  13 in total

1.  Generation of prions in vitro and the protein-only hypothesis.

Authors:  Rodrigo Diaz-Espinoza; Claudio Soto
Journal:  Prion       Date:  2010-04-05       Impact factor: 3.931

2.  A specific population of abnormal prion protein aggregates is preferentially taken up by cells and disaggregated in a strain-dependent manner.

Authors:  Young Pyo Choi; Suzette A Priola
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

3.  Comparison of abnormal isoform of prion protein in prion-infected cell lines and primary-cultured neurons by PrPSc-specific immunostaining.

Authors:  Misaki Tanaka; Ai Fujiwara; Akio Suzuki; Takeshi Yamasaki; Rie Hasebe; Kentaro Masujin; Motohiro Horiuchi
Journal:  J Gen Virol       Date:  2016-06-06       Impact factor: 3.891

4.  Prion fibrillization is mediated by a native structural element that comprises helices H2 and H3.

Authors:  Miquel Adrover; Kris Pauwels; Stephanie Prigent; Cesira de Chiara; Zhou Xu; Céline Chapuis; Annalisa Pastore; Human Rezaei
Journal:  J Biol Chem       Date:  2010-04-07       Impact factor: 5.157

5.  Distinct stability states of disease-associated human prion protein identified by conformation-dependent immunoassay.

Authors:  Young Pyo Choi; Alexander H Peden; Albrecht Gröner; James W Ironside; Mark W Head
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

6.  Globular domain of the prion protein needs to be unlocked by domain swapping to support prion protein conversion.

Authors:  Iva Hafner-Bratkovic; Romina Bester; Primoz Pristovsek; Lars Gaedtke; Peter Veranic; Jernej Gaspersic; Mateja Mancek-Keber; Matevz Avbelj; Magdalini Polymenidou; Christian Julius; Adriano Aguzzi; Ina Vorberg; Roman Jerala
Journal:  J Biol Chem       Date:  2011-02-15       Impact factor: 5.157

7.  PrPSc-Specific Antibody Reveals C-Terminal Conformational Differences between Prion Strains.

Authors:  Eri Saijo; Andrew G Hughson; Gregory J Raymond; Akio Suzuki; Motohiro Horiuchi; Byron Caughey
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

8.  Conformational properties of prion strains can be transmitted to recombinant prion protein fibrils in real-time quaking-induced conversion.

Authors:  Kazunori Sano; Ryuichiro Atarashi; Daisuke Ishibashi; Takehiro Nakagaki; Katsuya Satoh; Noriyuki Nishida
Journal:  J Virol       Date:  2014-07-30       Impact factor: 5.103

9.  Strain-Dependent Effect of Macroautophagy on Abnormally Folded Prion Protein Degradation in Infected Neuronal Cells.

Authors:  Daisuke Ishibashi; Takujiro Homma; Takehiro Nakagaki; Takayuki Fuse; Kazunori Sano; Hanae Takatsuki; Ryuichiro Atarashi; Noriyuki Nishida
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

10.  Structural conservation of prion strain specificities in recombinant prion protein fibrils in real-time quaking-induced conversion.

Authors:  Kazunori Sano; Ryuichiro Atarashi; Noriyuki Nishida
Journal:  Prion       Date:  2015       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.